| 000 | 01599 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515100828.0 | ||
| 264 | 0 | _c20080311 | |
| 008 | 200803s 0 0 eng d | ||
| 022 | _a1556-679X | ||
| 024 | 7 |
_a10.1128/CVI.00278-07 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEpaulard, Olivier | |
| 245 | 0 | 0 |
_aOptimization of a type III secretion system-based Pseudomonas aeruginosa live vector for antigen delivery. _h[electronic resource] |
| 260 |
_bClinical and vaccine immunology : CVI _cFeb 2008 |
||
| 300 |
_a308-13 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBacterial Vaccines _xgenetics |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aDose-Response Relationship, Immunologic |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGene Deletion |
| 650 | 0 | 4 |
_aGenes, Bacterial _xgenetics |
| 650 | 0 | 4 | _aLethal Dose 50 |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 |
_aOvalbumin _xgenetics |
| 650 | 0 | 4 |
_aProtein Transport _xgenetics |
| 650 | 0 | 4 |
_aPseudomonas aeruginosa _xgenetics |
| 650 | 0 | 4 |
_aQuorum Sensing _xgenetics |
| 650 | 0 | 4 |
_aVaccines, Attenuated _xgenetics |
| 650 | 0 | 4 |
_aVirulence Factors _xgenetics |
| 700 | 1 | _aDerouazi, Madiha | |
| 700 | 1 | _aMargerit, Carole | |
| 700 | 1 | _aMarlu, Raphaël | |
| 700 | 1 | _aFilopon, Didier | |
| 700 | 1 | _aPolack, Benoît | |
| 700 | 1 | _aToussaint, Bertrand | |
| 773 | 0 |
_tClinical and vaccine immunology : CVI _gvol. 15 _gno. 2 _gp. 308-13 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/CVI.00278-07 _zAvailable from publisher's website |
| 999 |
_c17606475 _d17606475 |
||